Idelalisib
ATC L01EM01 · 6 markets · 16 records
AU 5 records · 3 strengths
- 150 mgtabletZydeligZYDELIG idelalisib 100 mg tablet bottle
- 100 mgtabletZydeligZYDELIG idelalisib 100 mg tablet bottle
Records without a stated strength · 1 Zydelig
GB 4 records · 2 strengths
US 2 records · 2 strengths
CA 2 records · 2 strengths
ES 2 records · 1 strengths
- 100 mg/1 tablettabletZydelig
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Zydelig
| Strength / form / release | US | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|---|
| 150 mg tablet | Zydelig | Zydelig | Zydelig | Zydelig ZYDELIG idelalisib 100 mg tablet bottle | ||
| 100 mg tablet | Zydelig | Zydelig | Zydelig | Zydelig ZYDELIG idelalisib 100 mg tablet bottle | ||
| 100 mg/1 tablet tablet | Zydelig | |||||
unknown | Zydelig | Zydelig |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in ES and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en ES que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 ES 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 ES 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.